Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Biollaz

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
European Journal of Clinical Pharmacology|January 1, 1983
Hypertensive crisis treated with orally administered captoprilJ Biollaz, B Waeber, H R Brunner
Schweizerische Medizinische Wochenschrift|April 16, 1998
[Comparison of propacetamol and morphine in postoperative analgesia]P A Vuilleumier, T Buclin, J Biollaz
European Journal of Clinical Pharmacology|January 1, 1992
The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteersA Munafo, T Buclin, D Tuto, et al.
Revue Medicale Suisse|May 12, 2006
[Generic drugs and legal incentives: which impact?]F Livio, T Buclin, A Pannatier, et al.
British Journal of Anaesthesia|May 1, 1988
Grand mal seizure after extradural morphine analgesiaA Borgeat, J Biollaz, B Depierraz, et al.
Revue Medicale Suisse|May 12, 2006
[Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]L E Rothuizen, T Buclin, M Reichhart, et al.
Clinical Pharmacokinetics|January 1, 1997
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonistsC Csajka, T Buclin, H R Brunner, et al.
Revue Medicale Suisse|May 2, 2006
[Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings]J B Wasserfallen, S Shimia, J Biollaz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Chronic treatment of hypertensive patients with converting enzyme inhibitorsJ Nussberger, J Biollaz, B Waeber, et al.
British Journal of Clinical Pharmacology|January 22, 2003
NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratiosA Nyéki, T Buclin, J Biollaz, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Clinical Pharmacology|January 1, 1983
Hypertensive crisis treated with orally administered captoprilJ Biollaz, B Waeber, H R Brunner
Schweizerische Medizinische Wochenschrift|April 16, 1998
[Comparison of propacetamol and morphine in postoperative analgesia]P A Vuilleumier, T Buclin, J Biollaz
European Journal of Clinical Pharmacology|January 1, 1992
The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteersA Munafo, T Buclin, D Tuto, et al.
Revue Medicale Suisse|May 12, 2006
[Generic drugs and legal incentives: which impact?]F Livio, T Buclin, A Pannatier, et al.
British Journal of Anaesthesia|May 1, 1988
Grand mal seizure after extradural morphine analgesiaA Borgeat, J Biollaz, B Depierraz, et al.
Revue Medicale Suisse|May 12, 2006
[Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]L E Rothuizen, T Buclin, M Reichhart, et al.
Clinical Pharmacokinetics|January 1, 1997
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonistsC Csajka, T Buclin, H R Brunner, et al.
Revue Medicale Suisse|May 2, 2006
[Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings]J B Wasserfallen, S Shimia, J Biollaz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Chronic treatment of hypertensive patients with converting enzyme inhibitorsJ Nussberger, J Biollaz, B Waeber, et al.
British Journal of Clinical Pharmacology|January 22, 2003
NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratiosA Nyéki, T Buclin, J Biollaz, et al.
Pageof 16